Effectiveness of Rupture of Schatzki's Ring Using Biopsy Forceps Versus SIngle Dilation

NCT ID: NCT01200147

Last Updated: 2022-11-08

Basic Information

• Recruitment Status: WITHDRAWN
• Clinical Phase: NA
• Study Classification: INTERVENTIONAL
• Study Start Date: 2010-09-30
• Study Completion Date: 2010-09-30

Brief Summary

Dysphagia is a common reason for referal to the investigators Gastoenterology service. As many as 14% of patients undergoing radiological studies for dysphagia are found to have schatzki rings. Current recommendations for treatment of patients with symptomatic Schatzki rings are based on ancedotal experience and uncontrolled studies. The only randomized study on comparison of techniques the investigators were able to locate was published in 2000 and included only 26 patients. This study demonstrated that the biopsy techinque was as effective as and better tolerated than the standard dilation technique. Considering that the cost and time required for dilatation is greater than the basic biopsy technique, significant cost savings could be achieved using the biopsy technique. As well, patient satisfaction is an important factor considering that Schatzki rings can recur and repeated endoscopy is often required. Therefore, a study that shows a technique to be as or better than the current standard in effectiveness, cost, time, and patient comfort could lead to shift in current practice.

Detailed Description

None available, study was withdrawn

Conditions

Dysphagia; Schatzki Ring

Study Design

• Allocation Method: NA
• Intervention Model: SINGLE_GROUP
• Primary Study Purpose: TREATMENT
• Blinding Strategy: NONE

Study Groups

Study withdrawn no details

Group Type: NO_INTERVENTION

study withdrawn no details

Intervention Type: OTHER

Interventions

study withdrawn no details

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• Presenting to endoscopy unit with symptoms of dysphagia or known history of schatzki ring

Exclusion Criteria

• Prior esophageal or gastric surgery, severe esophagitis, coagulopathy

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 80 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Nova Scotia Health Authority

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Mark McMillan, MD FRCPC

Role: PRINCIPAL_INVESTIGATOR

Nova Scotia Health Authority

Locations

VG Hospital-Capital District Health Authority

Halifax, Nova Scotia, Canada

Countries

Canada

Other Identifiers

Schatzki-2010

Identifier Type: -

Identifier Source: org_study_id